Garden Grove, CA3 Active Studies

Ankylosing Spondylitis Clinical Trials in Garden Grove, CA

Find 3 actively recruiting ankylosing spondylitis clinical trials in Garden Grove, CA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
1,914
Enrolling

Recruiting Ankylosing Spondylitis Studies in Garden Grove

About Ankylosing Spondylitis Clinical Trials in Garden Grove

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 3 ankylosing spondylitis clinical trials recruiting participants in Garden Grove, CA. These studies are seeking a combined 1,914 participants. Research is being sponsored by ACADIA Pharmaceuticals Inc., Hoffmann-La Roche, AbbVie. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Garden Grove — FAQ

Are there ankylosing spondylitis clinical trials in Garden Grove?

Yes, there are 3 ankylosing spondylitis clinical trials currently recruiting in Garden Grove, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Garden Grove?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Garden Grove research site will contact you about next steps.

Are clinical trials in Garden Grove free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Garden Grove studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 3 active trials in Garden Grove are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov